ATE376840T1 - Gentherapeutika - Google Patents

Gentherapeutika

Info

Publication number
ATE376840T1
ATE376840T1 AT00908055T AT00908055T ATE376840T1 AT E376840 T1 ATE376840 T1 AT E376840T1 AT 00908055 T AT00908055 T AT 00908055T AT 00908055 T AT00908055 T AT 00908055T AT E376840 T1 ATE376840 T1 AT E376840T1
Authority
AT
Austria
Prior art keywords
gene
affinity
functional substance
efficacious amount
gene therapeutics
Prior art date
Application number
AT00908055T
Other languages
English (en)
Inventor
Ikunoshin Kato
Kiyozo Asada
Mitsuhiro Ueno
Kimikazu Hashino
Hirofumi Yoshioka
Keiji Tanaka
Original Assignee
Takara Bio Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takara Bio Inc filed Critical Takara Bio Inc
Application granted granted Critical
Publication of ATE376840T1 publication Critical patent/ATE376840T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10041—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/13043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2810/00—Vectors comprising a targeting moiety
    • C12N2810/40—Vectors comprising a peptide as targeting moiety, e.g. a synthetic peptide, from undefined source

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT00908055T 1999-03-23 2000-03-14 Gentherapeutika ATE376840T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP7859199 1999-03-23

Publications (1)

Publication Number Publication Date
ATE376840T1 true ATE376840T1 (de) 2007-11-15

Family

ID=13666162

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00908055T ATE376840T1 (de) 1999-03-23 2000-03-14 Gentherapeutika

Country Status (9)

Country Link
US (1) US20060166924A1 (de)
EP (1) EP1163912B1 (de)
KR (1) KR100674140B1 (de)
CN (1) CN1225285C (de)
AT (1) ATE376840T1 (de)
AU (1) AU2944100A (de)
DE (1) DE60036929T2 (de)
TW (1) TWI272107B (de)
WO (1) WO2000056368A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100888915B1 (ko) 2001-08-15 2009-03-16 다카라 바이오 가부시키가이샤 항원특이적 세포상해성 t 세포 확대배양방법
TW201043699A (en) 2002-03-25 2010-12-16 Takara Bio Inc Process for producing cytotoxic lymphocyte
EP1666589B1 (de) 2003-08-22 2010-02-17 Takara Bio Inc. Verfahren zur herstellung zytotoxischer lymphozyten
WO2007020880A1 (ja) 2005-08-17 2007-02-22 Takara Bio Inc. リンパ球の製造方法
WO2007040105A1 (ja) * 2005-09-30 2007-04-12 Takara Bio Inc. T細胞集団の製造方法
KR20220079799A (ko) * 2019-05-30 2022-06-14 이뮤노럭스 인터내셔널 코포레이션 예방접종 및 질환 요법을 위한 자가유래 유도 만능 줄기 세포와의 폭스바이러스의 용도

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5686278A (en) * 1994-03-25 1997-11-11 Indiana University Foundation Methods for enhanced retrovirus-mediated gene transfer
DE69520496T2 (de) * 1994-05-13 2001-07-12 Chiron Corp. (N.D.Ges.D. Staates Delaware), Emeryville Verfahren und zusammensetzungen als vehikel zur zielgerichtete einbringen von genen
GB9506466D0 (en) * 1994-08-26 1995-05-17 Prolifix Ltd Cell cycle regulated repressor and dna element
FR2726005B1 (fr) * 1994-10-10 1997-01-03 Adim Lignees immortalisees de cellules endotheliales cerebrales et leurs applications au traitement de differents troubles ou maladies primaires et secondaires neurologiques ou psychiatriques
AU709831B2 (en) * 1995-11-13 1999-09-09 Takara Bio Inc. Method for gene transfer into target cells with retrovirus
WO1997031656A1 (fr) * 1996-03-01 1997-09-04 Dnavec Research Inc. Composition pour introduire de maniere stable des genes dans des cellules hepatiques et procede pour introduire des genes a l'aide de cette composition
ATE350482T1 (de) * 1998-07-01 2007-01-15 Takara Bio Inc Gentransfermethoden

Also Published As

Publication number Publication date
EP1163912A4 (de) 2003-08-06
CN1225285C (zh) 2005-11-02
EP1163912B1 (de) 2007-10-31
KR20010102547A (ko) 2001-11-15
US20060166924A1 (en) 2006-07-27
DE60036929T2 (de) 2008-08-07
CN1345248A (zh) 2002-04-17
DE60036929D1 (de) 2007-12-13
WO2000056368A1 (en) 2000-09-28
KR100674140B1 (ko) 2007-01-26
AU2944100A (en) 2000-10-09
EP1163912A1 (de) 2001-12-19
TWI272107B (en) 2007-02-01

Similar Documents

Publication Publication Date Title
ATE308999T1 (de) Intrazellulare expression von carboxypeptidase g2 in enzyme-prodrug-therapie
DE50211045D1 (de) Medizinische aerosolformulierungen
TR200002355T2 (tr) 2-(Pürin-9-il)tetrahidrofüran-3,4-diol türevleri
HN1998000143A (es) Tetrahidronaftalenos substituidos y compuestos analogos.
EP1411118A4 (de) Zellproliferationsinhibitoren mit anti-glypican-3-antikörper
TR199800046A2 (xx) Aktif maddeler yarat�lmas� i�in n�kleik asit olu�umu.
BR0014282A (pt) Vacinas
EP1322307A4 (de) Verfahren zur behandlung von zellproliferationen störungen und virusinfektionen
SV2002000245A (es) Oxazolidinonas substituidas y su uso ref. lea 34122-sv
PT751939E (pt) Naftilamidas como agentes para o sistema nervoso central
DE60016798D1 (de) Papiertuch enthaltend antivirale wirkstoffe die hautfreundlich sind
DE60036929D1 (de) Gentherapeutika
DE60132443D1 (de) In lebenden zielzellen
NO20041773L (no) Farmasoytiske preparater for reduksjon av cellers aktivitet samt deres anvendelse.
EP1295611A4 (de) Verbindungen für den transfer von oligonukleotiden(03.01.02)
ES2124861T3 (es) Derivados de aminoacidos y su utilizacion como inhibidores de la encefalinasa.
TR200102024T2 (tr) Yeni tedavi.
DE69612056D1 (de) Terpenderivate (sarcodictyine) als antikrebsmittel
DE60003188D1 (de) Paracetamol und drotaverin enthaltende zusammensetzung
DK52685A (da) N,3-diacyl-2-oxindol-1-carboxamid-forbindelser og mellemprodukter ved deres fremstilling samt farmaceutisk praeparat
TR200201148T2 (tr) Haşerat ilacı terkipleri ve metodları.
ATE353642T1 (de) Verwendung von hypoestoxiden als antiparasitäre mittel
DK592885A (da) 2-azolylmethyl-3-difluorbenzyloxy-2,3-dihydrofluor-benzo(b)thiophener, fremgangsmaade til deres fremstilling og kompositioner indeholdendeforbindelserne
TR200102019T2 (tr) 3-izoksazolidinonların ve hidroksilamik asitlerin enfeksiyonların tedavisinde kullanılmaları.
FI20030379A0 (fi) Uusi farmaseuttinen koostumus

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties